Isabel Ruehl is a former editorial intern at Spectrum. She recently graduated from Columbia Journalism School and, before that, earned an M.Phil. in Health, Medicine and Society from Cambridge University in the United Kingdom.
Isabel Ruehl
Former news intern
Spectrum
From this contributor
‘Science working as it should’: Autism blood signature study earns open post-publication review
Shortly after the study’s publication, experts critiqued it on PubPeer and other online platforms.
‘Science working as it should’: Autism blood signature study earns open post-publication review
By
Isabel Ruehl
10 January 2023 | 5 min read
Whole-genome trove ties new genes, variants to autism
A massive update to the MSSNG dataset gives qualified researchers ready access to explore autism’s genetic architecture on a cloud-based platform.
Whole-genome trove ties new genes, variants to autism
By
Isabel Ruehl
12 December 2022 | 4 min read
Autism incidence in England varies by ethnicity, class, location
High rates of autism are linked to lower socioeconomic status and minority ethnic groups, according to the largest-ever autism incidence study.
Autism incidence in England varies by ethnicity, class, location
By
Isabel Ruehl
6 December 2022 | 5 min read
‘Assembloids’ lay bare autism-linked genes that hamper neuron development
The model enables the study of autism-linked genes at the earliest stages of neural development.
‘Assembloids’ lay bare autism-linked genes that hamper neuron development
By
Isabel Ruehl
30 November 2022 | 4 min read
Lab-grown ‘embryoids’ offer new window into gene-trait relationships
The developmental models have advantages over natural embryos and other synthetic models, such as organoids, but present technical and ethical challenges.
Lab-grown ‘embryoids’ offer new window into gene-trait relationships
By
Isabel Ruehl
26 October 2022 | 4 min read
Explore more from The Transmitter
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
By
Jill Adams
18 November 2025 | 2 min read